Kenya Rotavirus Vaccine Market Business Scenario Analysis By Global Industry Trend, and Opportunity Assessment till 2028

The Kenya Rotavirus Vaccine Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Kenya Rotavirus Vaccine market. This report explores all the key factors affecting the growth of the global Kenya Rotavirus Vaccine market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141655/

Report Overview

The Rotavirus Vaccine market size in Kenya stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Rotavirus infection is the most common cause of acute gastroenteritis in children under 5 years of age in Kenya. In 2009, the World Health Organization recommended that all countries, especially those with high diarrhoea-associated child mortality rates, implement rotavirus immunization programs. Rotavirus vaccination was introduced into the Kenya Expanded Programme on Immunization (KEPI) in 2014. Two of the vaccines (Rotarix and Rotateq),licensed by WHO are available in Kenya. Rotavirus vaccine has been well-received in Kenya due to the excellent clinical efficacy of both the vaccines. A substantial reduction of rotavirus-associated hospitalizations and all-cause diarrhoea has been observed in Kenya within 3 years of vaccine introduction.

Market Drivers

The market is majorly driven due to the high burden of diarrhoeal infections among infants and children under the age of 5 years in Kenya. Age distribution of rotavirus prevalence was as follows: 6 months-8.5%, 7-12 months-27.4%, 13-24 months - 41.4%, 25-36 months - 16.4% while 36-65 months had 6.3%.

Rotavirus diarrhoea was more common in wet and cold months of the year, the highest prevalence being observed in August (24.5%) in Kenya.

With financial support from GAVI (Global Alliance for Vaccines Initiatives), Kenya introduced the two-dose RV1 into the national immunization programme in July 2014. The vaccine is administered orally at 6 and 10 weeks of age and the goal is to protect more than 1.5 million children in the country from developing severe acute gastroenteritis.

Increased support from international organizations like UNICEF for large scale vaccination, supply availability, and access to affordable prices is another factor fuelling the rotavirus vaccines market.

To Know More About COVID-19 Impact On Kenya Rotavirus Vaccine Market @ https://www.prudentmarkets.com/sample-request/141655/

Market Segmentation

By Valency:

On the basis of Vaccine type, the Rotavirus vaccine market is segmented into Monovalent and Pentavalent Vaccine.

Rotarix is a Monovalent live attenuated rotavirus vaccine derived from a human rotavirus strain by serial passage in cell culture.

While RotaTeq is a pentavalent human-bovine reassortant vaccine, with the five most common human type specificities G1, G2, G3, G4 and P expressed individually on the genetic backbone of a bovine rotavirus strain naturally attenuated for humans

By End Users:

On the basis of End Users, the Rotavirus vaccine market is segmented into Hospitals, Clinics and Primary Health Centres, Academics and Research and Other users. The hospitals and PHCs segment are anticipated to have leading shares owing to the large number of suppliers and government support.

Major Players

According to Global Vaccine Market Report 2020 by World Health Organization (WHO), Vaccine manufacturing remains concentrated, with four large manufacturers (GSK, Pfizer, Merck, and Sanofi) controlling 90% of global vaccine value.

Rotarix is manufactured by GlaxoSmithKline (GSK) and is available in three presentations, and RotaTeq is manufactured by Merck & Co and is available in one presentation.

Rotarix, is administered orally in a 2-dose schedule, currently issued countrywide under the KEPI and RotaTeq, manufactured by Merck & Co. is administered orally in a 3-dose schedule, mostly in private facilities.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141655/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global Kenya Rotavirus Vaccine Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global Kenya Rotavirus Vaccine Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Kenya Rotavirus Vaccine market
Chapter 2: Exclusive Summary - the basic information of the Kenya Rotavirus Vaccine Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Kenya Rotavirus Vaccine
Chapter 4: Presenting the Kenya Rotavirus Vaccine Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the Kenya Rotavirus Vaccine market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/141655/

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the Kenya Rotavirus Vaccine Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.